Clone CellsHematopoietic Stem Cell TransplantationTransplantation, HomologousKidney TransplantationTransplantationTransplantsTransplantation, AutologousStem Cell TransplantationGraft vs Host DiseaseTissue DonorsGraft SurvivalHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionCytomegalovirus InfectionsImmunocompromised HostTransplantation ConditioningBone Marrow TransplantationTreatment OutcomeHistocompatibility TestingOpportunistic InfectionsRetrospective StudiesHeart TransplantationMycosesTime FactorsPeripheral Blood Stem Cell TransplantationCytomegalovirusLung TransplantationAspergillosisHistocompatibilityCyclosporineFetal Tissue TransplantationRoseolovirus InfectionsRecurrenceImmunosuppressionLiving DonorsPostoperative ComplicationsAntiviral AgentsTissue and Organ ProcurementBusulfanGanciclovirAntifungal AgentsCloning, MolecularBK VirusWhole-Body IrradiationTransplantation ImmunologyFatal OutcomePolyomavirus InfectionsRisk FactorsMolecular Sequence DataTacrolimusHepatic Veno-Occlusive DiseaseSurvival RateTransplantation ChimeraFollow-Up StudiesBase SequenceHematologic DiseasesSurvival AnalysisPolymerase Chain ReactionLeukemiaHerpesvirus 6, HumanWaiting ListsCell TransplantationMultiple MyelomaHLA AntigensLymphoproliferative DisordersAcute DiseaseCord Blood Stem Cell TransplantationProspective StudiesAnemia, AplasticCombined Modality TherapyIncidenceZygomycosisAmino Acid SequenceViral LoadHematopoietic Stem Cell MobilizationMycophenolic AcidDNA, ViralAllograftsAntilymphocyte SerumMyeloablative AgonistsSalvage TherapyTriazolesVirus DiseasesT-LymphocytesCadaverVirus ActivationLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaEpstein-Barr Virus InfectionsCystitisKidney Failure, ChronicPrognosisLeukemia, Myeloid, AcuteAdenoviridae InfectionsLiver FailureAntineoplastic Combined Chemotherapy ProtocolsFoscarnetStomatitisNeutropenia